These findings suggests that CYP24A1 polymorphisms may participate in the progression of CHD, and this is likely due to the effects of CYP24A1 on regulating the levels of vitamin D. Further studies are required to verify these results. This evidence concerns the gene CYP24A1 and coronary artery disorder.